主堡腿型苤查!Q!璺生!旦笠!!鲞箜!塑￡!也』QE!!!型塑!!：』也!!!!兰：y!!：i!：堕!：!学习新版临床指南进一步规范弱视诊断赵堪兴史学锋0厶f；，口7J【摘要】眼科临床指南(PPP)的引入，使我国眼科医师有机会接触和了解国际眼科PPP的制定原则、方法和应用价值，对快速提高我国眼科临床的诊疗水平，推动我国眼科临床诊疗规范化，促进国际交流起到了显著作用。由赵家良教授主译的PPP中译本第2版于2013年11月正式出版。新版PPP弱视分册采用了最新的证据分级和推荐意见标准，在循证基础上突出实用性；在弱视的定义方面，根据近年来国际研究的最新进展增加了新的解释；在弱视的诊断标准方面，对不同年龄段双眼弱视的最佳矫正视力标准有了新的界定；在弱视的检查方面，提供了从视力的定性评估方法、视力表的选择到睫状肌麻痹剂的使用等全面而实用的建议；在弱视的治疗方面，不仅根据最新的多中心临床随机对照试验的研究成果给出了强烈的建议，而且也明确地指出某些治疗措施尚缺乏足够证据支持；强调了停止弱视治疗后仍然需要定期随诊的必要性；在弱视的预防方面，指出了开展弱视的早期筛查的重要性，明确健康保健保险计划应当覆盖弱视的筛查、治疗和监察复发。本文就新版PPP弱视内容进行择要解读，以期与国内眼科同道一起进一步促进我国弱视诊断治疗的规范化。f中华胺科杂志，2014．50：48j-484)【关键词】弱视；诊疗准则LearnnewversionofPreferredPracticePatterntofurtherstandardizethediagnosisandtreatmentofamblyopiaZhaoKanxing．ShiXuefeng．ClinicalCollegeofOphthalmologyofnonjinMedicalUniversi0’，rianjinEyeHospitalandInstitute，TianjinKeyLaboratoO"ofOphthalmologyandVisualScience，Tianjin300020，ChinaCorrespondingauthor：ZhaoKanxing，Email：zkx4260@rip．163．com【Abstract】TheintroductionofPreferredPracticePatterns(PPP)intoChinahasgivenophthalmologistsinChinamoreopportunitiestoacquaintthemselveswithinternationalclinicalguidelinesforeyecare，includingitsdevelopingprinciples，methodsandtheapplicationvalue．IthadbroughtsignificanteffectsonthefastimprovementofclinicaleyecareandstandardizationofdiagnosisandtreatmentofeyediseasesinChina，andpromotedtheinternationalacademicexchanges．The2ndChineseversionofPPPstranslatedbyProf．JialiangZhaowasofficiallypublishedinNovember．2013．ThenewversionofPPPforamblyopiaadoptedtheneweststandardforgradingofevidencestrengthandrecommendationassessment，andemphasizesthepracticabilitybasedonevidence．Newexplanationsofthedefinitionofamblyopiaareaddedaccordingtotherecentresearchprogressesinamblyopia．Thediagnosticcriteriaofbestvisualacuityforbilateralamblyopiaatdifferentagesisgivenwithnewspecifications．Comprehensiveandpracticalsuggestionsontheexaminationmethodsforamblyopiaareprovidedfromthequalitativeassessmentofvisualacuity，thechoiceofeyechart，totheuseofcycloplegicagents．Intheaspectofthetreatmentofamblyopia，basedonthefindingsofrecentmulti—centralrandomcontrolledclinicaltrials，notonlystrongrecommendationsareprovided，butalsotheinsufficiencyofevidencesupposingforsomechoicesoftherapyispointedout．Thenecessityofthefollow-upevaluationafterthecessationofthetreatmentofamblyopiaisemphasizedtoo．Intheaspectofthepreventionofamblyopia，thenewamblyopiaPPPpointsouttheimportanceoftheearly-periodscreeningofamblyopia，andthattheheahhcareinsuranceplansshouldcovertimelyscreening，treatment，andmonitoringforrecurrenceofamblyopia．ThisarticledecipherstheessentialD01：10．3760／cma．j．issn．0412--4081．2014．07．001作者单位：300020天津医科大学眼科临床学院天津市眼科医院天津市眼科研究所天津市眼科学与视觉科学重点实验室通信作者：赵堪兴，Email：zkx4260@vip．163．COnl481．专家...
